Table of Contents
Epidemiology of Tuberculosis
Worldwide distribution of tuberculosis
Tuberculosis is found worldwide and is one of the most frequently encountered infectious diseases along with AIDS and malaria. According to the Robert Koch Institute (RKI), 1/3rd of the world population is infected with Mycobacterium tuberculosis, and during their lifetime, 5% to 10 % develop tuberculosis disease that requires treatment. Worldwide, tuberculosis is the bacterial infectious disease that most frequently leads to death even though it is treatable. Tuberculosis is the leading cause of death in patients with HIV.
Most individuals who are infected with Mycobacterium tuberculosis live in Africa, Southeast Asia, and the Western Pacific region.
Each year, almost 9 million people become sick with tuberculosis, and 1.4 million of these people die from the disease (WHO).
Risk of tuberculosis
Individuals at greater risk for tuberculosis include residents of countries with high prevalence of the disease, institutionalized patients, individuals who use intravenous drugs, and immunodeficient patients (e.g., those with diabetes mellitus or Hodgkin disease).
Individuals at high risk for tuberculosis include those with suspicious X-ray findings, those who have close contact with patients with active tuberculosis, and those who are HIV-infected or otherwise immunosuppressed. Countries with high risk for tuberculosis include Sub-Saharan Africa, the Indian subcontinent, and the former USSR.
Etiology and Pathogenesis of Tuberculosis
Pathogen and reservoir for tuberculosis
Tuberculosis pathogens are acid-fast, aerobic, gram-positive bacteria from the family of Mycobacteriaceae. In the following table, the pathogens of the Mycobacterium tuberculosis complex are listed with their respective reservoirs.
Pathogenically, these bacteria are especially effective at triggering a severe cell-mediated immune response.
Paths of infection for tuberculosis
The mode of transmission for infection with tuberculosis is almost exclusively airborne (droplet infection) via aerosols with droplets < 5 µm in diameter from patients with active/infectious tuberculosis.
- Frequency, duration, and closeness of contact with a patient with infectious tuberculosis
- Amount and virulence of the inhaled pathogen
- Susceptibility of the exposed person
Signs and Symptoms of Tuberculosis
Incubation time for tuberculosis
Typically, 6–8 weeks pass between exposure to the tuberculosis pathogen and measurable immune response. The risk of tuberculosis disease is greatest in the first 2 years following infection. Infants and immunosuppressed individuals have the greatest risk of developing the disease.
Clinical presentation of tuberculosis
Tuberculosis is not characterized by specific clinical manifestations. Primary tuberculosis, which is usually asymptomatic or presents as a flu, is often not recognized. In the event of the onset of the disease, most infected individuals later become ill from post-primary tuberculosis.
Primary tuberculosis is a latent infection that at first may be detected with a positive result from an indirect test for the pathogen (i.e. Mendel-Mantoux test). At this stage, there is no pathological radiological finding. The infected individual has mostly nonspecific symptoms, such as fatigue, or is asymptomatic. Pulmonary symptoms, such as a productive cough with hemoptysis, may develop.
If no radiological or other pathological changes are detectable, this stage of the disease is known as a latent tubercular infection (LTBI) based on a positive tuberculin reaction.
Approximately, 5–6 weeks after infection, a primary focus forms. In histology, the primary focus is characterized by a granuloma with epitheloid cells and Langhans giant cells with central caseation. Via the lymphogenic path of infection, the primary focus spreads to regional lymph nodes.
The primary focus of infection and reactive lymph nodes = primary complex.
Weeks or even months can pass until this primary complex (up to 90% of which is located in the lungs) heals completely. Often, scarred and calcified tissue remains, which can be detected in X-rays. Symptoms rarely occur at this point.
Important complications of primary tuberculosis
|Miliary tuberculosis||Pleuritis exsudativa tuberculosa||Landouzy sepsis|
|Genesis||Via hematogenous, lymphatic spread of tubercular bacilli from the primary complex||From foci close to the pleura|
|People affected||Children, immunodeficient adults||Teenagers and adults older than 40 years||Immunodeficient individuals|
|Symptoms||High fever, severe malaise||Systemic symptoms (e.g., fever, fatigue), thoracic pain, pleural effusion||Septic course of primary tuberculosis, high fever, spleen swelling, headache|
|Diagnosis||Chest X-ray: miliary spot shadowing; lumbar puncture: tubercular meningitis; ocular fundus: choroidal tubercles||Pleural puncture: exudation with low sugar concentration and increased adenosine-deaminase (ADA-test), chest X-ray|
|Therapy||Early, intensive parenteral chemotherapy||Tuberculosis standard therapy||Mostly lethal course|
Post-primary tuberculosis (chronic tuberculosis) refers to all forms of tuberculosis that follow primary infection. In most cases, the onset of disease is based on re-infection, not a new infection.
Features and symptoms of post-primary tuberculosis
- Apical pulmonary foci
- Simon foci: fuzzy, small, infraclavicular or supraclavicular spots
- Assmann’s early infiltrations
- A completely asymptomatic course is also possible
Great probability for detection of tubercular bacteria in sputum >> active, infectious tuberculosis
- Destruction and cavernization of growing areas of lung ⇒ hemoptysis
Tuberculosis can affect every organ system and trigger an unlimited variety of symptoms and complications. The following table gives an overview of the most important extrapulmonary manifestations of tuberculosis.
|Adrenal gland||Mostly bilateral, adrenal gland insufficiency (Addison’s disease)|
|CNS||Tubercular meningitis with typical nerve damage of the brain|
|Bones, joints, and cartilage
||Spondylitis tuberculosa, depression abscesses, laryngeal tuberculosis|
|Kidney||5 years after the infection at the earliest, hematuria with sterile pyuria|
|Pericardium||Pericardial effusion, pericarditis, constrictive pericarditis|
|Abdomen||Vomiting, diarrhea, abdominal pain, weight loss|
|Lymph nodes||Complications of primary tuberculosis, cervical lymph nodes are commonly involved, generalized lymphadenopathy|
|Skin||Lupus vulgaris (typically, in the cheek region of women), tuberculids|
Diagnosis of Tuberculosis
Medical history of tuberculosis
It is important to ask questions about previous infections, trips, and factors that increase risk of tuberculosis (e.g., HIV infection, alcohol abuse).
Tuberculin skin test and interferon-gamma test
The tuberculin skin test according to Mendel-Mantoux is positive if a palpable node of at least 15 mm is visible after 72–96 hours. For at-risk patients, an induration > 10 mm is sufficient to confirm an infection. For high-risk patients, an induration > 5 mm is sufficient to confirm infection.
The currently more established interferon-gamma test is based on the in-vitro stimulation of memory cells via antigens of Mycobacterium tuberculosis. Hereby, the lymphocytes of the patients are stimulated with a mixture of antigens of M. tuberculosis. If the patient was already affected by a tuberculosis infection or had contact with the pathogen, more interferon-gamma is produced.
Imaging of tuberculosis
Chest X-ray can help guide the diagnosis of tuberculosis, but findings may not be specific. The following might be visible on chest X-ray:
Primary complex: enlarged hilar lymph node, local shadowing
- Post-primary tuberculosis: Simon foci, Assmann’s infiltrations
- Nonspecific: Shadowing, calcification, caverns, pleural effusion, round foci (tuberculoma), the distinction between smooth (new) and hard infiltrations (old), foci mostly in the cranial lung regions.
CT scans may show hilar lymph nodes and retroclavicular infiltrations.
Diagnostic testing for tuberculosis
Diagnostic tests for tuberculosis include the threefold culture of morning sputum samples, one-time stomach fasting secretion, or invasive procedures, such as bronchoscopy, pleural puncture, or thoracoscopy with biopsy.
In patients with HIV infection, blood cultures are also performed because the hematogenous spread of tuberculosis (bacillemia) often occurs.
Acid-fast bacilli may be detected by using Ziehl-Neelsen stain or immunofluorescence stain with auramine. However, a negative finding does not exclude active pulmonary tuberculosis.
With polymerase chain reaction (PCR) analysis, mycobacteria can be detected within 48 hours. Additionally, this measure is characterized by very high sensitivity and specificity. However, PCR testing cannot distinguish between previous inflammation and active infection.
Differential Diagnosis for Tuberculosis
The most important differential diagnoses for pulmonary tuberculosis are:
Therapy for Tuberculosis
Drug therapy for tuberculosis
In 97% of cases, tuberculosis is curable. Every case of active tuberculosis requires treatment. The patient must be isolated until there is no more risk for infection. Normally, this state is reached at 4–6 weeks after initiation of therapy.
|Anti-tuberculosis drugs||Effect||Side effects|
|Isoniazid||Strongest anti-tuberculosis drug, bactericidal effect||Hepatotoxic, neurotoxic (polyneuropathy)|
|Rifampicin||Bactericidal (inhibition of DNA-dependent RNA-polymerase)||Hepatotoxic, reddish discoloration of bodily secretions|
|Pyrazinamide||Bactericidal||Hepatotoxic (transaminases, uric acid)|
|Ethambutol||Bacteriostatic or bactericidal, depending on the dose||Risk for opticus neuritis with loss of vision, central scotoma (therefore an ophthalmological examination is required before initiation of therapy)|
|Streptomycin||Bactericidal||Lesion of the vestibular nerve with balance disorders, ototoxicity; renal insufficiency|
Administration of medications for tuberculosis
- Overall duration: at least 6 months
- Initial phase: 2 months of standard therapy with isoniazid, rifampicin, pyrazinamide, and ethambutol
- Stabilization phase: 4 months of treatment with isoniazid and rifampicin, then monitoring of sputum over a period of 2 years
- Once daily: Mycobacteria have very slow growth kinetics. Thus, the medications must be administered every day all at once to reach synergistic peak levels
- Control of side effects: monitoring of liver function, kidney function, auditory function, X-rays, visual acuity testing
- Maximum doses must not be exceeded
Problems of treatment
- Diagnosis: culture is slow (4 weeks+)
- Compliance: no one likes taking tablets for several months
- Toxicity: especially the liver; raised LFTs common, may need to change treatment
- Drug resistance:
- Occurs if a patient is given single-agent therapy
- Need for extended treatment (12 months+)
- Extensively resistant disease is often fatal
Prophylaxis for Tuberculosis
Screening programs for tuberculosis
M. tuberculosis is exclusively transmitted among humans. Screening programs in areas with high risk for infection include tuberculin tests and X-ray images of the lungs.
In areas with low risk for infection, administration of the BCG (Bacille Calmette-Guérin) vaccination is not generally recommended. This vaccination is indicated for individuals at high risk of exposure (e.g., employees in shelters for homeless people).
Chemoprophylaxis for tuberculosis
Chemoprophylaxis should be considered if…
- A new occurrence of positive tuberculin reaction is present in a patient at risk for tuberculosis. Treatment is conducted with isoniazid for 9 months. In healthy individuals, initial management consists of X-ray monitoring (‘watchful waiting’).
- A child younger than 1 year is definitely exposed; monotherapy with isoniazid should be administered for 3 months.
- The interferon-gamma-test is positive and bacteriology is negative.